#ProCellEx - Twitter Hashtag

over 1 year ago

La plataforma #ProCellEx 🌱🧬 de #Protalix ya tiene dos productos en el mercado, genera ingresos y la empresa no tiene deuda. Casi no se ve algo así en small caps biotech. $PLX

Oninvest @oninvest_tech

over 1 year ago

Zacks Small-Cap Research values Protalix Biotherapeutics ($PLX) at $14 per share, nearly 500% above its current price of $2.5 Unlike many small biotechs, @Protalix_Bio generates revenue and has no debt, reducing investment risk. The company has two approved drugs: Elelyso (Gaucher disease) and Elfabrio (Fabry disease). It also has two pipeline candidates, including a gout treatment in early trials. With Q3 revenue up 75% to $17.8 million and a net profit of $3.2 million, #Protalix is gaining financial strength. HC Wainwright & Co also rates it a “buy” with a $15 target.

1

2

0

851

0

4

0

737

Cristian Desmarchelier @Cdesmarchelier

about 3 years ago

#Protalix all the way down to 61,8% fibonacci retracement area last month, now re-gaining and closing above 50% retracement for second straight day + MACD close to bullish crossover. $PLX #PlantBased #ProCellEx

Cdesmarchelier's tweet photo. #Protalix all the way down to 61,8% fibonacci retracement area last month, now re-gaining and closing above 50% retracement for second straight day + MACD close to bullish crossover. $PLX #PlantBased #ProCellEx https://t.co/iymNoSmgQP

2

1

0

472

Cristian Desmarchelier @Cdesmarchelier

about 3 years ago

After #FDA and #EMA approval and subsequent profit taking $PLX now hanging around 50% fibonacci retracement area. Will it hold? #Protalix #PlantBased #ProCellEx

Cdesmarchelier's tweet photo. After #FDA and #EMA approval and subsequent profit taking $PLX now hanging around 50% fibonacci retracement area. Will it hold?
#Protalix #PlantBased #ProCellEx https://t.co/jpuLWl9SQG

1

3

0

438

Cristian Desmarchelier @Cdesmarchelier

over 3 years ago

La israelí #Protalix está transformando el mundo de las proteínas terapéuticas: en mayo recibió aprobación de #EMA 🇪🇺 y #FDA 🇺🇸 para su segundo recombinante desarrollado en la plataforma de células vegetales #ProCellEx 🧬. Las implicancias son enormes. $PLX #PlantBased